Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: Executive summary from the tenth consensus conference of the acute dialysis quality initiative (ADQI)

Peter A. McCullough, Josee Bouchard, Sushrut S. Waikar, Edward D. Siew, Zoltan H. Endre, Stuart L Goldstein, Jay L Koyner, Etienne MacEdo, Kent Doi, Salvatore Di Somma, Andrew Lewington, Ravi Thadhani, Raj Chakravarthi, Can Ice, Mark D. Okusa, Jacques Duranteau, Peter Doran, Li Yang, Bertrand L. Jaber, Shane MeehanJohn A Kellum, Michael Haase, Patrick T. Murray, Dinna N Cruz, Alan Maisel, Sean M Bagshaw, Lakhmir S. Chawla, Ravindra L Mehta, Andrew D. Shaw, Claudio Ronco

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

83 Citations (Scopus)


Detection of acute kidney injury is undergoing a dynamic revolution of biomarker technology allowing greater, earlier, and more accurate determination of diagnosis, prognosis, and with powerful implication for management. Biomarkers can be broadly considered as any measurable biologic entity or process that allows differentiation between normal function and injury or disease. The ADQI (Acute Dialysis Quality Initiative) had its Ninth Consensus Conference dedicated to synthesis and formulation of the existing literature on biomarkers for the detection of acute kidney injury in a variety of settings. In the papers that accompany this summary, ADQI workgroups fully develop key concepts from a summary of the literature in the domains of early diagnosis, differential diagnosis, prognosis and management, and concurrent physiologic and imaging measures.

Original languageEnglish
Title of host publicationADQI Consensus on AKI Biomarkers and Cardiorenal Syndromes
Number of pages8
ISBN (Print)9783318024067
Publication statusPublished - 2013
Externally publishedYes

Publication series

NameContributions to Nephrology
ISSN (Print)03025144

Cite this